Contributors

Currently a Visiting Scholar at MIT, Victor McElheny has been writing and editing for publications including Science, The New York Times, and The Boston Globe for more than 50 years. On page 42 he takes a look, five years later, at the human genome project, also the subject of his upcoming third book. ?Many genomics predictions will take many years to fulfill,? McElheny says, ?yet the project has grown larger, more widespread, and more exciting than anyone predicted

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Currently a Visiting Scholar at MIT, Victor McElheny has been writing and editing for publications including Science, The New York Times, and The Boston Globe for more than 50 years. On page 42 he takes a look, five years later, at the human genome project, also the subject of his upcoming third book. ?Many genomics predictions will take many years to fulfill,? McElheny says, ?yet the project has grown larger, more widespread, and more exciting than anyone predicted.?

Glenn McGee directs the Alden March Bioethics Institute at the Albany­ Medical College. In the second of his regular columns (page 24), The editor in chief of The American Journal of Bioethics considers the Korean cloning scandal. ?Before we crucify the people involved,? he says, we must realize that ?research ethics have changed. In the past 10 years the problems have been less about evil scientists than about complicated relationships between different ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies